2012
DOI: 10.1016/j.addr.2012.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues

Abstract: Non-invasive treatment of injuries and disorders affecting bones and connective tissue is a significant challenge facing the medical community. A treatment route that has recently been proposed is nitric oxide (NO) therapy. Nitric oxide plays several roles in physiology with many conditions lacking adequate levels of NO. As NO is a radical, localized delivery via NO donors is essential to promoting biological activity. Herein, we review current literature related to therapeutic NO delivery in the treatment of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
105
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 117 publications
(111 citation statements)
references
References 164 publications
1
105
0
1
Order By: Relevance
“…Nitroglycerin, the most commonly used organic nitrate for clinically treating hypertension and angina pain, is known to release 1 mole equivalent of NO upon bioactivation by mitochondrial aldehyde dehydrogenase (mtALDH). 111 However, patients often develop nitrate tolerance (tachyphylaxis) after prolonged use because the reactive oxygen species generated by nitroglycerin can oxidize the thiol group of the mtALDH and result in enzyme dysfunction. 111,141143 This low bioavailability limits nitroglycerin’s use as an efficient NO donor and complicates clinical treatments.…”
Section: Nitric Oxide (No) To the Rescuementioning
confidence: 99%
See 2 more Smart Citations
“…Nitroglycerin, the most commonly used organic nitrate for clinically treating hypertension and angina pain, is known to release 1 mole equivalent of NO upon bioactivation by mitochondrial aldehyde dehydrogenase (mtALDH). 111 However, patients often develop nitrate tolerance (tachyphylaxis) after prolonged use because the reactive oxygen species generated by nitroglycerin can oxidize the thiol group of the mtALDH and result in enzyme dysfunction. 111,141143 This low bioavailability limits nitroglycerin’s use as an efficient NO donor and complicates clinical treatments.…”
Section: Nitric Oxide (No) To the Rescuementioning
confidence: 99%
“…Many different metal NO complexes have been reported, including manganese, 108,136 iron 144 and ruthenium-NO 108,111,136 complexes, with sodium nitroprusside (Na 2 [Fe(CN) 5 NO], SNP) being the most common. SNP is often used as a potent vasodilator in hypertensive emergencies, 144 which releases NO in the presence of reducing agents (e.g., thiol-containing compounds such as cysteine or glutathione) or by illumination with near-infrared or visible light.…”
Section: Nitric Oxide (No) To the Rescuementioning
confidence: 99%
See 1 more Smart Citation
“…As the complicated functions of NO are highly dependent on its concentration and duration [28], NO delivery systems that can deliver NO donors to the target sites and control the NO release are prerequisite to realize the full potential of NO [34]. Current progress of NO delivery systems is summarized in details in references 3134.…”
Section: Introductionmentioning
confidence: 99%
“…O uso potencial do NO para tratar lesão no tendão, apresenta a necessidade de controlar concentrações localizadas de NO para promover e não inibir a deposição de colágeno. Uma solução de albumina de soro bovino nitrosada tem sido utilizada como carreadora e liberadora de NO [66].…”
Section: Funções Do Nounclassified